Abstract

Cardiotrophin-like cytokine factor 1 (CLCF1) is secreted as a complex with the cytokine receptor-like factor 1 (CRLF1). Syndromes caused by mutations in the genes encoding CLCF1 or CRLF1 suggest an important role for CLCF1 in the development and regulation of the immune system. In mice, CLCF1 induces B-cell expansion, enhances humoral responses and triggers autoimmunity. Interestingly, inactivation of CRLF1, which impedes CLCF1 secretion, leads to a marked reduction in the number of bone marrow (BM) progenitor cells, while mice heterozygous for CLCF1 display a significant decrease in their circulating leukocytes. We therefore hypothesized that CLCF1 might be implicated in the regulation of hematopoiesis. To test this hypothesis, murine hematopoietic progenitor cells defined as Lin−Sca1+c-kit+ (LSK) were treated in vitro with ascending doses of CLCF1. The frequency and counts of LSK cells were significantly increased in the presence of CLCF1, which may be mediated by several CLCF1-induced soluble factors including IL-6, G-CSF, IL-1β, IL-10, and VEGF. CLCF1 administration to non-diseased C57BL/6 mice resulted in a pronounced increase in circulating myeloid cells, which was concomitant with augmented LSK and myeloid cell counts in the BM. Likewise, CLCF1 administration to mice following sub-lethal irradiation or congeneic BM transplantation (BMT) resulted in accelerated LSK recovery along with a sustained increase in BM-derived CD11b+ cells. Altogether, our observations establish an important and unforeseen role for CLCF1 in regulating hematopoiesis with a bias toward myeloid cell differentiation.

Highlights

  • Hematopoiesis is a tightly regulated process involving numerous factors controlling the balance between hematopoietic stem cells (HSC) self-renewal and lineage commitment [1]

  • This is exemplified by the fact that IL-6, which is produced by bone marrow (BM)-resident mesenchymal stem cells, acts synergistically with IL-3 to induce HSC and progenitor cell proliferation [2, 3]

  • We report in this study a potent role for Cardiotrophin-like cytokine factor 1 (CLCF1) on hematopoietic multipotent progenitor cell proliferation in vitro with a myeloid-biased hematopoiesis in both healthy animals and following immunoablation

Read more

Summary

INTRODUCTION

Hematopoiesis is a tightly regulated process involving numerous factors controlling the balance between hematopoietic stem cells (HSC) self-renewal and lineage commitment [1]. Besides the role played by HSC-specific transcription factors, cytokines of the IL-6 family have been shown to exert important functions in the regulation of HSC biology This is exemplified by the fact that IL-6, which is produced by BM-resident mesenchymal stem cells, acts synergistically with IL-3 to induce HSC and progenitor cell proliferation [2, 3]. In addition to IL-6, a role for leukemia inhibitor factor (LIF; another member of the IL-6 cytokine family) has been proposed for stem cell survival and proliferation as its administration to mice increases the counts of megakaryocyte progenitor cells both in the BM and spleen [6, 7]. Mice lacking CRLF1 display a strong decrease in hematopoietic progenitor cell numbers [13] These observations led us to examine whether CLCF1 exerts an effect on hematopoiesis. We report in this study a potent role for CLCF1 on hematopoietic multipotent progenitor cell proliferation in vitro with a myeloid-biased hematopoiesis in both healthy animals and following immunoablation

MATERIALS AND METHODS
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call